The emerging treatment of the medication represents a major development in the care of type 2 diabetes. Unlike existing drugs, tirzepatide targets dual pathways – the GLP-1 hormone and glucose-dependent https://tirzepatidepeptide402539.livebloggs.com/48807759/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment